Published in Thromb Res on February 13, 2010
New players in haemostasis and thrombosis. Thromb Haemost (2014) 1.29
Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood (2013) 1.19
Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding. Am J Respir Cell Mol Biol (2015) 0.83
The role of galectin-3 and galectin-3-binding protein in venous thrombosis. Blood (2014) 0.80
Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes. Am J Transl Res (2016) 0.75
Proteomic profiling of plasma microparticles following deep-vein thrombosis. Expert Rev Proteomics (2010) 0.75
A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus. Clin Proteomics (2017) 0.75
Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content. Sci Rep (2016) 0.75
Avascular Necrosis of the Femoral Head: Are Any Genes Involved? Arch Bone Jt Surg (2015) 0.75
More powerful procedures for multiple significance testing. Stat Med (1990) 17.12
Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood (2007) 4.73
Mechanisms of thrombus formation. N Engl J Med (2008) 4.67
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res (2006) 2.43
Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost (2001) 2.38
P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A (1994) 2.00
Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol (2008) 1.93
Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation (1997) 1.67
P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med (2000) 1.61
A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost (2001) 1.53
The many faces of tissue factor. J Thromb Haemost (2009) 1.48
Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost (2009) 1.46
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res (2009) 1.43
The platelet microparticle proteome. J Proteome Res (2005) 1.42
The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp Cell Res (2008) 1.24
Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and -independent mechanisms. Arterioscler Thromb Vasc Biol (2001) 1.19
New horizons in the analysis of circulating cell-derived microparticles. Keio J Med (2004) 1.16
Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost (2007) 1.12
Early events of Bacillus anthracis germination identified by time-course quantitative proteomics. Proteomics (2006) 1.10
Neutrophils and deep venous thrombosis. Haemostasis (1993) 1.04
Fibrinogen gamma chain functions. J Thromb Haemost (2003) 1.00
Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis. Anticancer Res (2009) 0.96
On the trail of microparticles. Circ Res (2009) 0.93
X-ray crystallographic studies on fibrinogen and fibrin. J Thromb Haemost (2003) 0.92
The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB J (2007) 0.91
Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood. Blood (1995) 0.91
Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis (2000) 0.86
Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study. Clin Appl Thromb Hemost (2009) 0.86
Chronic venous insufficiency is associated with elevated level of circulating microparticles. J Thromb Haemost (2009) 0.80
Multidetector computed tomography for acute pulmonary embolism. N Engl J Med (2006) 7.57
Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A (2010) 5.69
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg (2004) 3.41
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood (2004) 3.31
von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood (2010) 2.82
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation (2005) 2.67
Quantifying changes in the thiol redox proteome upon oxidative stress in vivo. Proc Natl Acad Sci U S A (2008) 2.65
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res (2006) 2.43
Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics (2006) 2.29
The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2011) 2.15
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med (2006) 2.13
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology (2007) 2.09
Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med (2003) 2.03
Murine thrombosis models. Thromb Haemost (2004) 1.98
Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg (2013) 1.95
Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol (2008) 1.93
Pediatric sleep questionnaire: prediction of sleep apnea and outcomes. Arch Otolaryngol Head Neck Surg (2007) 1.76
Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg (2005) 1.76
Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation. J Cell Biol (2011) 1.72
Differential regulation of aortic growth in male and female rodents is associated with AAA development. J Surg Res (2008) 1.72
Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J (2008) 1.71
The Escherichia coli GTPase CgtAE is involved in late steps of large ribosome assembly. J Bacteriol (2006) 1.67
P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg (2003) 1.64
Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes. J Vasc Surg (2003) 1.63
A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg (2010) 1.59
Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg (2012) 1.55
Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol (2005) 1.53
Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2004) 1.51
Organellar proteomics: analysis of pancreatic zymogen granule membranes. Mol Cell Proteomics (2005) 1.49
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol (2004) 1.49
Subjective sleepiness and polysomnographic correlates in children scheduled for adenotonsillectomy vs other surgical care. Sleep (2006) 1.48
The Michigan Surgical Quality Collaborative: a legacy of Shukri Khuri. Am J Surg (2009) 1.48
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg (2007) 1.47
Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg (2006) 1.47
Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol (2012) 1.46
L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation (2005) 1.44
Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr Med Chem (2009) 1.43
Social and emotional impact of strabismus surgery on quality of life in children. J AAPOS (2005) 1.39
Tissue loss, early primary graft occlusion, female gender, and a prohibitive failure rate of secondary infrainguinal arterial reconstruction. J Vasc Surg (2002) 1.39
Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg (2002) 1.39
Attending, house officer, and medical student perceptions about teaching in the third-year medical school general surgery clerkship. J Am Coll Surg (2004) 1.39
Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg (2002) 1.37
Validated MALDI-TOF/TOF mass spectra for protein standards. J Am Soc Mass Spectrom (2007) 1.35
A true aneurysm of the profunda femoris artery: a case report and review of the English language literature. Ann Vasc Surg (2004) 1.34
Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg (2005) 1.34
ProteomeCommons.org collaborative annotation and project management resource integrated with the Tranche repository. J Proteome Res (2010) 1.31
Noninvasive treatment of deep venous thrombosis using pulsed ultrasound cavitation therapy (histotripsy) in a porcine model. J Vasc Interv Radiol (2010) 1.30
Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol (2006) 1.30
Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg (2005) 1.30
Vaginal birth and de novo stress incontinence: relative contributions of urethral dysfunction and mobility. Obstet Gynecol (2007) 1.29
Sonographic elasticity imaging of acute and chronic deep venous thrombosis in humans. J Ultrasound Med (2006) 1.29
A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 1.29
Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J Proteome Res (2009) 1.29
Rab27b localizes to zymogen granules and regulates pancreatic acinar exocytosis. Biochem Biophys Res Commun (2004) 1.29
Levator plate angle in women with pelvic organ prolapse compared to women with normal support using dynamic MR imaging. Am J Obstet Gynecol (2006) 1.27
Surgeon specialty and provider volumes are related to outcome of intact abdominal aortic aneurysm repair in the United States. J Vasc Surg (2003) 1.27
Comprehensive phosphoprotein analysis of linker histone H1 from Tetrahymena thermophila. Mol Cell Proteomics (2006) 1.26
Tranche distributed repository and ProteomeCommons.org. Methods Mol Biol (2011) 1.25
Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost (2010) 1.23
Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms. Ann N Y Acad Sci (2006) 1.22
Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg (2011) 1.22
Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost (2008) 1.22
The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci (2003) 1.20
Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes (2011) 1.20
Proteomic analysis of the Vibrio cholerae type II secretome reveals new proteins, including three related serine proteases. J Biol Chem (2011) 1.20
Interleukin-6: a potential target for post-thrombotic syndrome. Ann Vasc Surg (2010) 1.18